In GBM, CD155 promotes TIGIT+ immune cell infiltration and the transition of the circulating NK cells to TIGIT+/CD226- phenotype, while normally TIGIT+ NK cells are absent in the CNS and peripheral blood (82). This evidence concerns the gene PVR and glioblastoma.